FDA Inspection 768901 — Teva Pharmaceuticals USA Inc

Teva Pharmaceuticals USA Inc — FEI 1938125

The FDA completed an inspection of Teva Pharmaceuticals USA Inc on Feb 9, 2012 in Mexico, MO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 9, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Mexico, MO (United States)